retatrutide phase 2 results 2024 2025 press release New weight-loss drug rivaling bariatric surgery? Here's what the new data actually show. #weightlossjourney #retatrutide #obesity Today, we shared new data

84 LabouesseM

Large-scale clinical trials have demonstrated that GLP-1RAs predominantly exhibit neutral or suppressive effects on overall cancer risk, with semaglutide showing no elevated cancer incidence [14], while significant reductions have been observed in specific malignancies, particularly liver cancers and prostate cancers [13, 15]

L-carnitine can come in a variety of forms

economy by a trillion dollars in the next four years, more or less, because of their potential to improve health outcomes and boost productivity

This curated kit is designed specifically for postpartum women who are beginning GLP-1 therapy and want to protect their metabolism, maintain muscle, and support healthy nutrition while losing weight

Trends Pharmacol Sci 43(8):641652 Kashyap SN, Boyle NR, Roberson ED (2023) Preclinical interventions in mouse models of frontotemporal dementia due to progranulin mutations